0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syringe — RxCUI 855200
RxNorm drug concept · Semantic clinical drug
RxCUI 855200
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI855200
Official name0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asganirelix acetate 250 MCG in 0.5 ML Prefilled Syringe; ganirelix acetate 250 MCG per 0.5 ML Prefilled Syringe
FDA products mapped10
Package NDCs mapped11
Reported Medicaid activity (SDUD)138 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syr... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syringe
RxCUI 855200 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Ganirelix
35825IN -
Ganirelix acetate
259264PIN
-
Ganirelix
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Fyremadel
2587590BN
-
Fyremadel
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ganirelix Prefilled Syringe
746562SCDF -
Ganirelix acetate Prefilled Syringe
2649337SCDFP -
Ganirelix Injectable Product
1156701SCDG -
Ganirelix acetate Injectable Product
2661943SCDGP -
Ganirelix Prefilled Syringe [Fyremadel]
2587593SBDF -
Ganirelix acetate Prefilled Syringe [Fyremadel]
2658128SBDFP -
Fyremadel Injectable Product
2587592SBDG -
Prefilled Syringe
721656DF - +1 more in this family
-
Ganirelix Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ganirelix acetate 0.5 MG/ML
855199SCDC -
0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syringe [Fyremadel]
2587594SBD -
Ganirelix acetate 0.5 MG/ML [Fyremadel]
2587591SBDC
-
Ganirelix acetate 0.5 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ganirelix acetate 0.5 MG/ML
SCDC · 855199 -
Ganirelix Prefilled Syringe
SCDF · 746562 -
Ganirelix acetate Prefilled Syringe
SCDFP · 2649337 -
Ganirelix Injectable Product
SCDG · 1156701 -
Ganirelix acetate Injectable Product
SCDGP · 2661943
Brand-Name Concepts
-
0.5 ML ganirelix acetate 0.5 MG/ML Prefilled Syringe [Fyremadel]
SBD · 2587594 -
Ganirelix acetate 0.5 MG/ML [Fyremadel]
SBDC · 2587591 -
Ganirelix Prefilled Syringe [Fyremadel]
SBDF · 2587593 -
Ganirelix acetate Prefilled Syringe [Fyremadel]
SBDFP · 2658128 -
Fyremadel Injectable Product
SBDG · 2587592 -
Fyremadel
BN · 2587590
📦 FDA Products & Package NDCs
10 products · 11 package NDCs
11 package NDCs map to RxCUI 855200 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00548-5001-00 | 1 SYRINGE in 1 CARTON (0548-5001-00) / .5 mL in 1 SYRINGE | Ganirelix Acetate | Amphastar Pharmaceuticals, Inc. | 2022-06-20 |
| 55566-1010-01 | 1 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1... | Fyremadel | Ferring Pharmaceuticals Inc. | 2022-02-28 |
| 65219-0028-05 | 1 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYR... | Ganirelix Acetate | Fresenius Kabi USA, LLC | 2023-03-24 |
| 67184-0574-01 | 1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLAS... | Ganirelix Acetate | Qilu Pharmaceutical Co., Ltd. | 2025-05-15 |
| 68083-0472-01 | 1 BLISTER PACK in 1 CARTON (68083-472-01) / 1 SYRINGE, GLAS... | GANIRELIX ACETATE | Gland Pharma Limited | 2023-02-28 |
| 70700-0327-98 | 1 SYRINGE, GLASS in 1 CARTON (70700-327-98) / 1 mL in 1 SYR... | Ganirelix Acetate | Xiromed LLC | 2024-04-01 |
| 70748-0274-01 | 1 TRAY in 1 CARTON (70748-274-01) / 1 SYRINGE, GLASS in 1 T... | Ganirelix Acetate | Lupin Pharmaceuticals, Inc. | 2024-02-14 |
| 71288-0554-80 | 1 BLISTER PACK in 1 CARTON (71288-554-80) / 1 SYRINGE, GLAS... | Ganirelix Acetate | Meitheal Pharmaceuticals Inc. | 2022-06-06 |
| 78206-0138-01 | 1 BLISTER PACK in 1 CARTON (78206-138-01) / 1 SYRINGE, GLAS... | Ganirelix Acetate | Organon LLC | 2021-06-01 |
| 78206-0138-02 | 1 BLISTER PACK in 1 CARTON (78206-138-02) / 1 SYRINGE, GLAS... | Ganirelix Acetate | Organon LLC | 2024-02-16 |
| 83301-0082-01 | 1 SYRINGE, GLASS in 1 CARTON (83301-0082-1) / .5 mL in 1 SY... | Ganirelix Acetate | Mullan Pharmaceutical Inc. | 2026-05-05 |
Observed labelers:
Organon LLC (2) ·
Amphastar Pharmaceuticals, Inc. (1) ·
Ferring Pharmaceuticals Inc. (1) ·
Fresenius Kabi USA, LLC (1) ·
Gland Pharma Limited (1) ·
Lupin Pharmaceuticals, Inc. (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.